Sign In
Buy SNDX
$18.34
-0.0500 (-0.272%)
At Close: Jun 03, 2026
Editas (EDIT) Moves Ahead With its Portfolio Reprioritization
06:10pm, Friday, 20'th Jan 2023 Zacks Investment Research
Editas (EDIT) enters into a deal with Shoreline Biosciences for licensing Editas proprietary gene editing technologies and cell franchise.
Syndax (SNDX) Is a Great Choice for 'Trend' Investors, Here's Why
01:50pm, Friday, 20'th Jan 2023 Zacks Investment Research
Syndax (SNDX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "
Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication
12:34pm, Friday, 20'th Jan 2023 Zacks Investment Research
The FDA grants accelerated approval to Seagen's (SGEN) Tukysa in combination with trastuzumab for previously treated HER2-positive metastatic colorectal cancer.
Syndax (SNDX) Is a Great Choice for 'Trend' Investors, Here's Why
10:32am, Friday, 20'th Jan 2023
Syndax (SNDX) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "
Roche (RHHBY) Tecentriq Meets Adjuvant Liver Cancer Study Goal
03:26pm, Thursday, 19'th Jan 2023 Zacks Investment Research
Roche's (RHHBY) phase III IMbrave050 study, evaluating Tecentriq plus Avastin for treating early-stage hepatocellular carcinoma, meets its primary endpoint.
Angion (ANGN) Down on Merger Agreement With Private Biotech
05:45pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
Angion (ANGN) inks a definitive merger agreement with privately-held Elicio Therapeutics. The combined company's lead pipeline candidate will be ELI-002, a therapeutic cancer vaccine targeting mKRAS-d
Are You Looking for a Top Momentum Pick? Why Syndax Pharmaceuticals (SNDX) is a Great Choice
05:00pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
Does Syndax Pharmaceuticals (SNDX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Are You Looking for a Top Momentum Pick? Why Syndax Pharmaceuticals (SNDX) is a Great Choice
01:33pm, Wednesday, 18'th Jan 2023
Does Syndax Pharmaceuticals (SNDX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Syndax Pharmaceuticals (SNDX) Gains As Market Dips: What You Should Know
11:15pm, Tuesday, 17'th Jan 2023 Zacks Investment Research
In the latest trading session, Syndax Pharmaceuticals (SNDX) closed at $26.46, marking a +0.57% move from the previous day.
Incyte (INCY) Up 7% in a Year: Will the Momentum Continue?
02:36pm, Tuesday, 17'th Jan 2023 Zacks Investment Research
Incyte (INCY) outperforms the biotech industry in the past year and the momentum is anticipated to continue in 2023 as well.
First Wave (FWBI) IND Filing Under FDA's Review, Stock Up
06:06pm, Monday, 16'th Jan 2023 Zacks Investment Research
First Wave's (FWBI) stock gains as FDA reviews its IND amendment for the planned phase II study of an enhanced enteric microgranule delivery formulation of adrulipase.
Biogen (BIIB) Partner Eisai Seeks Nod for Lecanemab in Japan
05:33pm, Monday, 16'th Jan 2023 Zacks Investment Research
Biogen's (BIIB) partner Eisai files a marketing authorization application for lecanemab for treating early Alzheimer's disease in Japan.
Are Medical Stocks Lagging Acer Therapeutics (ACER) This Year?
02:40pm, Monday, 16'th Jan 2023 Zacks Investment Research
Here is how Acer Therapeutics Inc. (ACER) and Syndax Pharmaceuticals (SNDX) have performed compared to their sector so far this year.
Roche (RHHBY) Gets EU Approval for Xofluza in New Patient Base
05:38pm, Thursday, 12'th Jan 2023 Zacks Investment Research
The European Commission approves Roche's (RHHBY) Xofluza for treating uncomplicated influenza and post-exposure prophylaxis of influenza in children aged one year and above.
ETON Up as FDA Accepts NDA for Dehydrated Alcohol Injection
03:34pm, Thursday, 12'th Jan 2023 Zacks Investment Research
Eton (ETON) gains as the its new drug application (NDA) for dehydrated alcohol injection for methanol poisoning is accepted for review by the FDA.
